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Abstract
Cyclin T1 is a regulatory subunit of a general RNA polymerase II elongation factor known as P-TEFb. Cyclin T1 is also required
for Tat transactivation of HIV-1 LTR-directed gene expression. Translation of Cyclin T1 mRNA has been shown to be
repressed in human monocytes, and this repression is relieved when cells differentiate to macrophages. We identified miR-
198 as a microRNA (miRNA) that is strongly down-regulated when monocytes are induced to differentiate. Ectopic
expression of miR-198 in tissue culture cells reduced Cyclin T1 protein expression, and plasmid reporter assays verified miR-
198 target sequences in the 39 untranslated region (39UTR) of Cyclin T1 mRNA. Cyclin T1 protein levels increased when an
inhibitor of miR-198 was transfected into primary monocytes, and overexpression of miR-198 in primary monocytes
repressed the normal up-regulation of Cyclin T1 during differentiation. Expression of an HIV-1 proviral plasmid and HIV-1
replication were repressed in a monocytic cell line upon overexpression of miR-198. Our data indicate that miR-198
functions to restrict HIV-1 replication in monocytes, and its mechanism of action appears to involve repression of Cyclin T1
expression.
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Introduction
Productive transcription of eukaryotic protein-coding genes
requires a processive form of RNAP II to overcome pauses
resulting from negative elongation factors. The positive transcrip-
tion elongation factor, P-TEFb, plays a critical role in converting
RNAP II to a processive enzyme through phosphorylation of the
C-terminal domain of RNAP II and negative elongation factors
[1,2]. P-TEFb is composed of Cyclin-dependent kinase 9 (CDK9)
as the catalytic subunit and Cyclin T1, T2, or K as the regulatory
subunit [3,4]. Although there are multiple Cyclin partners for
CDK9, Cyclin T1-containing P-TEFb (Cyclin T1/P-TEFb) is the
major cellular form in cell types examined thus far and it has been
studied extensively because of its involvement in HIV-1 gene
expression [5]. The HIV-1 Tat transactivator protein recruits
Cyclin T1/P-TEFb to the TAR RNA structure of viral transcripts,
resulting in a switch from an abortive transcription process to a
highly processive one, and this greatly enhances viral gene
expression and is essential for viral replication [6].
Unlike Cyclins involved in cell cycle progression, the expression
level of Cyclin T1 is usually independent of cell cycle stages.
However, Cyclin T1 has been shown to be regulated in human
peripheral blood lymphocytes (PBLs), primary CD4
+ T cells, and
monocytes/macrophages. In PBLs and CD4
+ T cells, activation
from a resting state results in a strong up-regulation of Cyclin T1
protein expression through a mechanism that involves post-
transcriptional regulation [7–9]. Cyclin T1 expression is low in
freshly isolated monocytes and increases significantly when cells
are induced to differentiate into macrophages [10]. The induction
of Cyclin T1 in macrophages correlates with a permissive state for
HIV-1 replication, as monocytes do not support HIV-1 replication
[11]. Additionally, Cyclin T1 protein expression is shut-off at late
times of macrophage differentiation by proteasome-mediated
proteolysis, but it can be re-induced by macrophage activation
or HIV-1 infection [10,12].
The increase in Cyclin T1 protein expression in monocytes
plays an important role in macrophage differentiation, as an
shRNA depletion of Cyclin T1 in a monocytic cell line prevents
the up-regulation of over 20% of mRNAs normally induced when
these cells are stimulated to differentiate into macrophages [13].
We have previously observed that although Cyclin T1 protein
expression is very low in freshly isolated primary monocytes,
Cyclin T1 mRNA levels are high, suggesting that translation of
this mRNA may be actively suppressed in monocytes [10,14].
Given the approximate 5 kb length of the Cyclin T1 39UTR [15],
a miRNA(s) may be responsible for this repression. MicroRNAs
are non-coding small RNAs of about 22 nucleotides in length that
function in metazoans through base-pairing preferentially with the
39UTR of target mRNAs, resulting in translational inhibition or in
some cases mRNA degradation [16–18]. A number of studies have
linked miRNAs to the regulation of specific gene functions, cell
fate transition, malignant transformation, and especially hemato-
poietic lineage commitment [19–21].
In this study, we examined the miRNA expression profile
during the early stage of primary human monocytes differentiation
into macrophages. This analysis identified miR-198 as a negative
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sequences in the 39UTR of Cyclin T1 mRNA. We found that
inhibition of miR-198 function in primary monocytes resulted in
increased Cyclin T1 protein levels, and overexpression of miR-198
in differentiating monocytes repressed the normal Cyclin T1 up-
regulation. Inhibition of Cyclin T1 up-regulation by miR-198 in a
monocytic cell line also resulted in decreased HIV-1 proviral gene
expression and HIV-1 replication, indicating that miR-198
possesses an anti-HIV-1 function that appears to function through
the repression of an essential cellular cofactor.
Results
Identification of miRNAs as candidates for repressors of
Cyclin T1 protein expression in monocytes
Cyclin T1 protein expression is induced by a post-transcrip-
tional mechanism when human primary monocytes are cultured in
vitro under conditions that allow macrophage differentiation [10].
Given the ,4.6 kb 39UTR in the Cyclin T1 mRNA (see below),
we wished to examine changes in miRNAs expression during
monocyte to macrophage differentiation, as miRNAs that are
down-regulated during differentiation are candidates for repressors
of Cyclin T1 protein expression. We isolated total RNA from both
monocytes and macrophages allowed to differentiate in vitro from
two healthy blood donors. A microarray platform was used to
examine expression levels of 321 validated human miRNAs in
these RNA preparations (see Materials and Methods).
Using criteria and statistical analysis described in Material and
Method, we identified several miRNAs that were differentially
expressed in monocyte and macrophages from both donors
(Figure 1A). Of these miRNAs, nine were up-regulated (red in
heat map) and 13 were down-regulated (green in heat map) in
macrophages relative to monocytes. Thus, a total of 22 out of 321
miRNAs examined showed reproducible differential expression
during monocyte to macrophage differentiation. To monitor the
reliability of the miRNA microarray data, we selected four
miRNAs for end-point RT-PCR analysis with commercially
available primer sets. As shown in Figure 1B, increased amounts
of PCR products for miR-155 were detected in RNA samples from
macrophages relative to monocytes, in agreement with the
microarray data which showed an induction of miR-155.
Reductions in the levels of miR-26a and miR-223 in macrophages
were detected in the PCR assays, again in agreement with the
microarray data in which both of these miRNAs were down-
regulated. Finally, the levels of miR-24 were similar between
monocyte and macrophages in the PCR assays, in agreement with
microarray data that showed a constant level of miR-24
expression. These results indicate that the microarray data are
likely to be reliable in general.
Identification of Cyclin T1 poly(A) signal
To identify miRNAs that might repress Cyclin T1 mRNA
translation, we wished to search Cyclin T1 mRNA sequences for
potential target sites for the 13 miRNAs found to be down-
regulated during monocyte differentiation. Cyclin T1 mRNA is
ubiquitously expressed as a ,8 kb transcript and because the
coding sequence of Cyclin T1 only requires 2178 nucleotides and
the 59UTR is approximately 330 nucleotides in length, it has an
extensive 39 untranslated region (39UTR) that has not been
characterized [4,22]. The alignment of human EST sequences and
the full-length goat Cyclin T1 mRNA sequence suggest that the
39UTR of human Cyclin T1 mRNA is contained within a single
exon [15]. An analysis of the 8 kb sequence downstream of the
Cyclin T1 stop codon revealed seven potential poly(A) signals
(AATAAA) (Figure 2A). To determine the 39UTR sequences for
miRNA target predictions, we first characterized the poly(A) signal
usage in the Cyclin T1 mRNA by RT-PCR.
RNA samples from cell lines, primary CD4
+ lymphocytes, and
monocytes/macrophages were examined to determine if alterna-
tive poly(A) signals are utilized for the Cyclin T1 39UTR. Using an
RT primer that anneals to the start of the poly(A) sequences and
PCR primers specific for each poly(A) signal (P1 to P5, Figure 2A),
we were able to amplify a discrete band of ,400 bp only with
primer P4 (Fig 2B). Extension times in PCR reactions were 45
seconds to maximize the expected ,400 bp product that would be
produced by the primer nearest to the major poly(A) site. These
data suggest that the fourth poly(A) signal is utilized to produce the
majority of Cyclin T1 mRNA in the cell types examined. The
absence of PCR products in reactions without reverse transcrip-
tion excludes the possibility of genomic DNA contamination in
PCR reactions. A BLAST search revealed two cDNA clones with
only three or four nucleotide differences with the P4-PCR product
(Figure 2C), further supporting the conclusion that the fourth
poly(A) signal is used predominantly. Based upon these results, we
conclude that Cyclin T1 mRNA arises predominantly from
utilization of the fourth poly(A) signal and its length is ,7.1 kb
(plus poly(A) sequences). Additionally, this analysis found no
evidence of alternative poly(A) site selection in CD4
+ lymphocytes
and monocyte/macrophages. This deduced Cyclin T1 39UTR
was used for miRNA target site predictions.
Ectopic expression of miR-198 down-regulates
endogenous Cyclin T1 without affecting the mRNA levels
We selected several down-regulated miRNAs, including miR-
15b, miR-26a, and miR-198, for initial experiments. These three
miRNAs were down-regulated .2-fold in our microarray data
with monocytes/macrophages and each are predicted to have
.five target sites in the Cyclin T1 mRNA 39UTR with minimum
free energies (mfe) less than -20 kcal/mol. In gain-of-function
experiments, precursors for these miRNAs were transfecting into
293T cells and Cyclin T1 protein expression was examined in
immunoblots. Cyclin T1 protein levels were reduced in 293T cells
transfected with the miR-198 precursor (pre-miR-198) relative to
Author Summary
Monocytes do not support HIV-1 replication, in part
because they do not express adequate levels of essential
cellular cofactors that mediate steps in the viral replication
cycle. Monocytes become permissive for viral replication
upon differentiation to macrophages, indicating that
cellular cofactors are induced during the differentiation
process. One such cofactor is Cyclin T1, which is not
expressed in monocytes and is expressed at high levels
following macrophage differentiation. Cyclin T1 functions
to greatly stimulate the amount of HIV-1 produced in the
infected cell. We identified a microRNA (miRNA) named
miR-198 that represses the expression of Cyclin T1 in
monocytes. miRNAs block expression of proteins by
binding to messenger RNAs and preventing their transla-
tion by ribosomes. The expression levels of miR-198 are
greatly reduced in macrophages, and this appears to allow
translation of Cyclin T1 mRNA and expression of Cyclin T1
protein. Our study indicates that this miRNA restricts HIV-1
replication in monocytes. We think that it is possible, if not
likely, that additional miRNAs in monocytes also restrict
HIV-1 replication by repressing other essential cellular
cofactors.
miR-198 Represses Cyclin T1
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had no significant effect (Figure 3A). Similar to the results with the
pre-miR-15b transfection, the miR-26a precursor did not affect
Cyclin T1 protein expression (data not shown). SiRNAs that target
the Cyclin T1 coding region were used as a positive control for
transfection, and these siRNAs successfully knocked down Cyclin
T1 protein expression.
To further validate the effect of miR-198 on Cyclin T1 protein
expression, increasing amounts of pre-miR-198 were transfected
into HeLa cells, and a dose-dependent reduction in Cyclin T1
protein level was seen (Figure 3B). A control miRNA precursor,
pre-miR-Control, did not affect Cyclin T1 expression. Addition-
ally, miR-198 did not affect Cyclin T1 mRNA levels, which
remained constant in cells transfected with pre-miR-198
(Figure 3C). The levels of b-actin and GAPDH mRNAs also
remained unchanged following transfection of pre-miR-198,
suggesting that miR-198 overexpression has no impact on overall
mRNA levels. These data demonstrate that miR-198, a miRNA
which is down-regulated during monocyte to macrophage
differentiation, is capable of down-regulating Cyclin T1 protein
expression. Because the ectopic expression of miR-198 reduces
Cyclin T1 protein levels without affecting Cyclin T1 mRNA levels,
it is likely that miR-198 acts through translational inhibition as is
common for miRNAs.
Identification of miR-198 target sites in the 39UTR of
Cyclin T1 mRNA
We found that miR-198 is predicted to have .10 potential
target sites in the 39UTR of Cyclin T1 mRNA with mfe lower
than 220 kcal/mol (see Materials and Methods). To determine if
the Cyclin T1 39UTR can be regulated by miR-198, we inserted
the full length 39UTR between the luciferase coding sequence and
the poly(A) signal of the pGL3 firefly luciferase vector driven by
CMV immediate early promoter (pU3-full, Figure 4B). An shRNA
vector was generated to express miR-198 (shmiR-198) from the
pCL-based retroviral vector. An shRNA designed to target green
fluorescence protein, shGFP, was also generated as a control. Pools
of HeLa cells expressing shGFP or shmiR-198 were generated by
infection of cells with shRNA retroviruses and subsequent
puromyocin selection. Reporter plasmids were then transfected
into shGFP- or shmiR-198-expressing HeLa cells along with a
renilla luciferase reporter plasmid (pTK-RL) as an internal control
for transfection efficiency. Additionally, p198T, which contains
sequences with perfect complementarity to miR-198, was included
Figure 1. MiRNA expression profile during monocyte to macrophage differentiation. (A) Heat map for all differentially expressed miRNAs
in two blood donors. Each color block represents the ratio of miRNA expression levels of monocytes to macrophages. Red indicates an induction and
green indicates a reduction of expression in macrophages, with color intensity correlating with level of change. The fold-change of selected miRNAs
is shown above or below the blocks. Positive number indicates an induction and negative number indicates a reduction. (B) Expression of miR-26a,
miR-155, miR-223, and miR-24 were evaluated in semi-quantitative PCR assays. Equal amounts of RNA from the indicated RNA preparations from the
two donors were used in end-point PCR assays. Negative controls (2) were reaction mixtures without RNA and positive controls (+) were reaction
mixtures with human total heart RNA. Quantification of band intensities is shown below each PCR product.
doi:10.1371/journal.ppat.1000263.g001
miR-198 Represses Cyclin T1
PLoS Pathogens | www.plospathogens.org 3 January 2009 | Volume 5 | Issue 1 | e1000263as a positive control that should be repressed through an siRNA
pathway. As shown in Figure 5A, the relative expression of the
positive control p198T was repressed in cells expressing shmiR-
198 relative to cells expressing shGFP, showing more than a 60%
reduction. The parental pVector expressed at a slightly higher
level in shmiR-198-expressing cells. Expression of pU3-full was
also repressed by ,40%, suggesting that there are miR-198 target
sites in the Cyclin T1 39UTR.
To identify the locations of these target sites, we divided the full-
length 39UTR into four overlapping fragments (U3-1 to U3-4) and
inserted them into to the pGL3 vector (pU3-1 to pU3-4, Figure 4A
and 4B). Only expression from the pU3-1 and pU3-4 reporters
showed a statistically significant repression in shmiR-198-express-
ing cells, demonstrating a 30% and a 20% reduction for pU3-1
and pU3-4, respectively (Figure 5A). It appears therefore that
target sites for miR-198 reside in these two fragments, consistent
with recent findings that miRNA target sites are generally locate
away from the center of a 39UTR [23].
There were three predicted target sites in fragment U3-1 and
U3-4 with mfe,225 kcal/mol, and they were designated site
2478, site 2867, and site 6502 according to their locations in the
Cyclin T1 mRNA (Figure 4A, first nucleotide in coding sequence
defined as +1). All three predicted targets show extensive of
complementarity with miR-198 at their 59 ends. However, site
6502 contains additional eight nucleotides at its 39 end
complementary to the miR-198 seed sequence (Figure 4C), which
closely resembles the structure of the 59-dominant canonical
miRNA target site [24]. Expression of reporter plasmids
containing two or three copies of site 2478 (p2478), site 2867
(p2867), or site 6502 (p6502) in the 39UTR of the luciferase gene
was assayed in cells expressing either shmiR-198 or shGFP
(Figure 5A). A control reporter plasmid, pCtrl, which contains
three copies of unrelated sequences, expressed at similar levels in
both shmiR-198- and shGFP-expressing cells. Expression of p2867
was reduced a relatively modest 20% in shmiR-198-expressing
cells, while expression of p2478 was unaffected perhaps due to a
sub-optimal seed sequence. Expression of p6502 was significantly
repressed by shmiR-198, showing a 40–50% reduction in shmiR-
198-expressing cells relative to control cells. Therefore, site 2867 in
fragment U3-1 and especially site 6502 in fragment U3-4 appear
to be responsible for repression mediated by miR-198 in Cyclin T1
mRNA 39UTR. Although both of the sites have similar binding
energies, site 6502 showed greater sensitivity to shmiR-198 when
compared to site 2867. When site 6502 along with its adjacent
sequences was clone into the reporter plasmid (p6502g-WT,
Figure 4B) and assayed, a ,50% reduction was observed in
shmiR-198-expressing cells relative to shGFP-expressing cells
(Figure 5A). In addition, mutation of three nucleotides in the site
6502 which are complementary to the mRNA seed sequence
abolished the inhibition by shmiR-198 (Figures 4C and 5A),
strongly suggesting the direct targeting of miR-198 to site 6502
and highlighting the importance of the seed match present in site
6502 during miRNA-mediated repression.
To verify that repression of Cyclin T1 protein expression by
miR-198 requires target sequences in the Cyclin T1 39UTR, we
carried out a plasmid transfection experiment with a HA-tagged
Cyclin T1 expression plasmid lacking the Cyclin T1 39UTR. The
HA-Cyclin T1 plasmid was co-transfected with a precursor for
either miR-198 (pre-miR-198) or a pre-miR-Control. To verify
that the transfected pre-miR-198 was biologically active, we co-
transfected the p198T luciferase control plasmid (Figure 4C) that is
repressed by miR-198 by a siRNA pathway. Additionally, a renilla
luciferase reporter plasmid was co-transfected to monitor trans-
fection efficiency and siRNAs against Cyclin T1 were included in a
control co-transfection. The siRNAs against the HA-Cyclin T1
were very effectively in reducing protein expression but had little
Figure 2. Cyclin T1 mRNA utilizes the fourth poly(A) signal downstream of the coding sequence. (A) A schematic representation of Cyclin
T1 mRNA with 39UTR end and potential poly(A) signals. The first nucleotide in the coding sequence is defined as +1. The indicated Reverse
Transcription primer (T7-(TTT)6-V) contains T7 promoter sequence for PCR amplification and mixed nucleotides (V; A, C, and G) at the 39 end for
specific amplification from the beginning of the poly(A) sequences. Forward primers for PCR (P1 to P5) are indicated by forward arrows. (B) Reverse
transcription was conducted with DNase I-treated RNA from HeLa cells, 293T cells, resting and activated primary CD4
+ T cells, primary monocytes, and
macrophages using primer T7-(TTT)6-V. PCR reactions with primers specific for T7 sequences and each utilized poly(A) signal (P1 to P5) is predicted to
yield PCR products of ,400 bp in length. An agarose gel as shown with products results for primer P4 and control reactions. (C) The sequence of the
PCR product obtained with P4 primer shows sequence similarity with two cDNA clones, BX537514 (CoreNucleotide search) and AI832083 (EST search)
in GenBank. Arrows indicate differences in nucleotide sequences between the product with the P4 primer and EST sequences.
doi:10.1371/journal.ppat.1000263.g002
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Although the pre-miR-198 was able to reduce expression of the
p198T reporter plasmid about 20-fold relative to the pre-miR
control, it had no inhibitory effect on Cyclin T1 expression and
even appeared to stimulate Cyclin T1 expression. These data
indicate that the repression of Cyclin T1 protein expression by
miR-198 requires target sequences in the Cyclin T1 mRNA
39UTR.
miR-198 regulates Cyclin T1 protein expression during in
vitro monocyte to macrophage differentiation
The data presented above demonstrate that miR-198 can target
sequences in the Cyclin T1 mRNA 39UTR and can repress
expression of endogenous Cyclin T1 protein expression when
ectopically expressed. To examine whether miR-198 regulates
Cyclin T1 expression in primary monocytes, we isolated primary
monocytes and macrophages from two donors (Donor3 and
Donor4) and first re-examined the correlation between miR-198
expression and Cyclin T1 protein levels. In agreement with our
previous results [10,14], Cyclin T1 protein levels were strongly up-
regulated in macrophages relative to monocytes (Figure 6A).
Additionally, although Cyclin T1 protein expression is induced in
macrophages, Cyclin T1 mRNA levels were reduced from 20 to
60% when compared to levels on monocytes (Figure 6B), similar to
our previous results [10,14]. In agreement with the microarray
data shown in Figure 1A, miR-198 levels were reduced in
macrophages relative to monocytes, showing a 14-fold reduction
in Donor3 and a 19-fold reduction in Donor4. Although both
Cyclin T1 mRNA and miR-198 levels were decreased in
macrophages, the ratio between Cyclin T1 mRNA and miR-198
increased in macrophages. This observation indicates that in
macrophages there are more copies of Cyclin T1 mRNA for each
copy of miR-198.
In loss-of-function experiments, we examined the effects of a
miR-198 inhibitor on Cyclin T1 expression in monocytes. We
transfected a chemically modified single-stranded nucleic acid
inhibitor of miR-198 (anti-miR-198) into freshly isolated mono-
cytes. As shown in Figure 6C, anti-miR-198 was able to induce
Cyclin T1 levels from two- to six-fold in two donors examined
(Donor 3, 4). In an additional gain-of-function experiment,
transfection of pre-miR-198 to overexpress miR-198 in monocytes
induced to differentiate with GM-CSF treatment resulted in about
a 3-fold decrease in Cyclin T1 protein levels (Figure 6C, right
panel). The effects of miR-198 on Cyclin T1 expression are
consistent with recent quantitative proteomic studies that have
shown that in most cases miRNAs influence proteins levels about
1.5- to 2-fold [25,26]. These data in primary monocytes further
support the proposal that miR-198 plays a role in repressing
Cyclin T1 protein expression in monocytes, and the reduction in
miR-198 levels during macrophage differentiation contributes to
induction of Cyclin T1 protein expression. The induction of
Cyclin T1 has been shown to be important for the program of
gene expression in macrophages [13].
miR-198 represses HIV-1 proviral expression and HIV-1
replication
In addition to cellular genes that are dependent on Cyclin T1
for expression, HIV-1 Tat-mediated gene expression is highly
dependent upon Cyclin T1. We therefore examined if down-
regulation of Cyclin T1 by miR-198 could result in decreased
HIV-1 proviral expression. We used a promonocytic cell line,
Mono Mac 6 (MM6) for these experiments, as we previously
determined that this cell line is a useful model to investigate the
role of Cyclin T1 function in monocyte differentiation [13]. Cyclin
T1 is up-regulated in MM6 cells treated with PMA for 48 hours
(Figure 7A, left panel), similar to its induction during primary
monocyte to macrophage differentiation. Ectopic expression of
miR-198 in MM6 cells from a transfected shmiR-198 plasmid,
followed by PMA treatment, largely prevented Cyclin T1 up-
regulation (Figure 7A, right panel). In contrast, transfection of a
control shGFP plasmid resulted in similar Cyclin T1 levels as those
seen in mock-transfected cells.
To examine if HIV-1 proviral gene expression is affected by the
down-regulationofCyclinT1bymiR-198,aHIV-1NL4-3luciferase
proviral reporter plasmid was co-transfected with shGFP or shmiR-
198 plasmid into MM6 cells. A renilla luciferase reporter plasmid,
pTK-RL, was also co-transfected as an internal control. Cells were
treated with PMA, harvested 48 hours after transfection, and divide
into two equal portions forluciferase assays and immunoblot analysis.
The results of two independent experiments are shown in Figure 7B;
in one of these experiments, duplicate transfections were performed.
Luciferase assays revealed that expression of the HIV-1 proviral
reporter plasmid was approximately nine-fold lower in shmiR-198-
expressing cells than in shGFP-expressing cells, and the results of
immunoblots indicated that this reduction correlated with decreased
Cyclin T1 protein levels. These data suggest that miR-198 is capable
of repressing HIV-1 proviral expression by targeting its cellular
cofactor Cyclin T1.
Figure 3. Ectopic expression of miR-198 down-regulates
endogenous Cyclin T1 protein levels without affecting its
mRNA levels. (A) 293T cells were transfected with 150 pmole of pre-
miR-198, pre-miR-15b, or siRNA against Cyclin T1 (siCyclin T1) and
examined for Cyclin T1 and b-actin protein expression at 72 hours after
transfection. IB: immunoblot. (B) Increasing amounts of pre-miR-198
(6.25 pmole to 100 pmole) or pre-miR-Control (100 pmole) were
transfected into HeLa cells. Cells were harvest at 72 hours post-
transfection to examine the levels of Cyclin T1 and a-tubulin protein
expression. (C) Cyclin T1 mRNA levels were examined by RT-real-time
PCR and normalized to a-tubulin mRNA levels in pre-miR-198- and miR-
Control-transfected HeLa cells. b-actin and GAPDH mRNA levels were
also normalized to a-tubulin mRNA. The data shown here are
means6SDs of three independent transfections.
doi:10.1371/journal.ppat.1000263.g003
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expression of miR-198, MM6 cells were transfected with a shGFP
control or shmiR-198 plasmid and cells were treated with PMA
immediately after transfection. Cultures were infected with M-
tropic HIV-1 strain SF162 after one day of PMA treatment and
p24 expression in culture supernatants was measured at either
three or four days post-infection in two independent experiments
(Figure 7C). A 25% reduction in p24 expression was observed
when expression was examined at three days post-infection, while
a 50% reduction was observed when p24 expression was examined
at four days post-infection. The greater inhibition of proviral
reporter plasmid expression by miR-198 in Figure 7B than in the
HIV-1 infection in Figure 7C is likely the result of transfection
efficiency. In the proviral reporter plasmid experiment, both the
reporter plasmid and the miR-198 shRNA vector were co-
transfected and it is therefore likely that the majority of transfected
cells contained both plasmids. In the HIV-1 infection experiment,
it is likely that a significant portion of infected cells were not
transfected with the miR-198 shRNA vector. The data in
Figure 7C further suggest that miR-198 is capable of repressing
HIV-1 replication through down-regulation of the essential
cofactor Cyclin T1.
Effects of HIV-1 infection on miR-198 expression in
macrophages
It has been reported that miRNA expression shows distinct
patterns in HIV-1 provirus plasmid-transfected HeLa cells [27].
Therefore, we wished to examine if HIV-1 infection affects miR-
198 expression in macrophages. Macrophages isolated from
healthy blood donors were allowed to differentiate for four days,
and were infected with a M-tropic HIV-1 SF162 strain for seven
days, and RNA was isolated for miR-198 quantification.
Measurements of p24 expression were performed at day four
and seven post-infection to verify productive infections (data not
shown). As shown in Figure 8A, miR-198 levels increased modestly
to 1.9-fold in Donor 6 and 3.8-fold in Donor 7 when normalized
Figure 4. miR-198 target sequences in the Cyclin T1 mRNA 39UTR. (A) Schematic representation of Cyclin T1 mRNA. Three predicted miR-198
target sequences, site 2478, site 2867, and site 6502, are shown and named according to the position of their first nucleotide in Cyclin T1 mRNA. (B)
The indicated luciferase reporter plasmids based upon the CMV immediately-early promoter were constructed by inserting the indicated sequences
between the firefly luciferase gene and poly(A) signal. pU3-4 contains additional sequences not included in Cyclin T1 39UTR and is indicated with
underlined number. (C) Predicted binding structures and energies (RNAhybrid) between miR-198 and the three predicted target sequences and
control sequences as shown. The three nucleotides in site 6502 in bold font were mutated from gga to cct in p6502g-Mut.
doi:10.1371/journal.ppat.1000263.g004
miR-198 Represses Cyclin T1
PLoS Pathogens | www.plospathogens.org 6 January 2009 | Volume 5 | Issue 1 | e1000263to U6B snRNA. These data suggest that HIV-1 infection up-
regulates miR-198 levels in macrophages. Cyclin T1 mRNA levels
also increased 1.8-fold in Donor 6 and 1.6-fold in Donor 7, while
a-tubulin mRNA levels remained the same (Figure 8B). Cyclin T1
protein expression is induced in HIV-1-infected macrophages, and
this has been shown to involve an inhibition of proteasome-
mediated proteolysis of Cyclin T1 [12]. The data shown on
Figure 7B indicates that a relatively modest increase in Cyclin T1
mRNAs may contribute to the induction in Cyclin T1 protein
expression in infected macrophages. The significance in the
modest increase in miR-198 levels in HIV-1 infected macrophages
remains to be elucidated.
Discussion
Our finding that miR-198 represses Cyclin T1 protein
expression in monocytes provides mechanistic insight into previous
observations that translation of Cyclin T1 mRNA is inhibited in
these cells [10,14]. Because Cyclin T1 is a component of P-TEFb,
a general RNA polymerase II elongation factor, miR-198 is likely
to broadly regulate gene expression in monocytes through its own
targeting functions and through indirect effects on Cyclin T1-
dependent genes. It is important to note that P-TEFb function is
not deficient in monocytes, as these cells express high levels of
Cyclin T2, an alternative Cyclin subunit of P-TEFb [13,28].
Figure 5. Identification of functional miR-198 target sites in Cyclin T1 39UTR. (A) Reporter plasmids described in Figure 4B were co-
transfected with a renilla luciferase internal control reporter (thymidine kinase promoter) into shGFP- or shmiR-198-expressing HeLa cell pools.
Luciferase activities for firefly and renilla were measured 24 hours post-transfection. Relative luciferase activities (firefly luciferase activity by renilla
luciferase activity, FL/RL) were measured for each plasmid. Relative expression was obtained after normalizing of FL/RL in shmiR-198-expressing cells
to that in shGFP-expressing cells transfected. The data shown here are means6SDs of three independent transfections. * Students t-test P-value
,0.001 compared to pVector. ** Students t-test P-value ,0.001 compared to pCtrl. (B) An expression plasmid for HA-Cyclin T1, the p198T firefly
luciferase reporter plasmid (Figure 4B) and a TK-renilla luciferase plasmid were co-transfected into HeLa cells with either pre-miR-control, pre-miR-198
or siRNAs against Cyclin T1. Cell extracts were prepared at 24 hours post-transfection and were used for luciferase assays and an immunoblot. The
indicated ratios of firefly luciferase to renilla luciferase (FL/RL) was determined.
doi:10.1371/journal.ppat.1000263.g005
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and are also capable of broadly regulating gene expression
through indirect mechanisms. For example, miRNA lin-4 targets
lin-14 in C. elegans [29,30] and in neuronal cells, miR-124 targets
the RNAP II CTD phosphatase SCP1, a component of the REST
transcription repressor complex [31].
miR-198 and HIV-1 replication in monocytes
Freshly isolated monocytes do not support viral replication and
must undergo a program of macrophage differentiation to become
permissive for HIV-1 replication [11]. Viral entry is not limiting in
monocytes, but reverse transcription and nuclear import of the
pre-integration complex are defective [32,33]. Because Tat is
essential for HIV-1 replication [6] and Cyclin T1 is a critical Tat
cofactor, miR-198 can function in monocytes as an additional
repressor of viral gene expression and replication (Figure 6B and
6C). MiRNAs have previously been reported to regulated Tat
function, as the miRNA cluster miR-17/92 is capable of inhibiting
HIV-1 replication through repression of the histone acetyltrans-
ferase PCAF that also participates in Tat function [34].
We observed that HIV-1 infection of macrophages modestly
induces both miR-198 and Cyclin T1 mRNA expression levels
Figure 6. miR-198 functions to repress Cyclin T1 protein expression in primary monocytes. (A) Expression levels of Cyclin T1 and b-actin
proteins in freshly isolated monocytes (d0) or macrophages allowed to differentiate for five days (d5) were examined in immunoblots for two donors.
(B) Expression levels of Cyclin T1 mRNA relative to b-actin mRNA were measured by RT-real-time PCR assay; expression levels of miR-198 were
measured using TaqMan MicroRNA assays. The relative abundance was calculated by normalizing of b-actin mRNA or miR-198 levels. Bars represent
range in three measurements. (C) miR-198 inhibitor (anti-miR-198) or control inhibitor (anti-miR-Control) were transfected into freshly isolated
monocytes from two donors (Donor 3, 4). miR-198 precursor (pre-miR-198) or control precursor (pre-miR-Control) were transfected into freshly
isolated monocytes and differentiation was induced with GM-CSF treatment (Donor 5). Cells were harvested by direct lysis at times indicated after
transfection and Cyclin T1 protein expression was examined in immunoblots. Quantification of Cyclin T1 protein levels is shown below each band
(normalized to b-actin).
doi:10.1371/journal.ppat.1000263.g006
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expression in macrophages [12], it is possible that following up-
regulation of Cyclin T1 mRNA and protein by infection, a cellular
negative-feed back loop is activated that results in elevated levels of
miR-198 and a subsequent dampening of the induction of Cyclin T1.
Down-regulation of miR-198 and up-regulation of Cyclin
T1 during monocyte differentiation
The up-regulation of Cyclin T1 protein expression is an
important event during monocyte differentiation, as shRNA
depletions and transcriptional profiling have shown that Cyclin
T1 is required for expression of more than 20% of the mRNAs
that are induced during the differentiation program [13]. Because
miR-198 restricts Cyclin T1 expression in monocytes, this miRNA
may contribute to the prevention of a transcriptional program of
differentiation. The reduction of expression of miR-198 is
therefore likely to be important for monocyte differentiation.
Furthermore, genes involved in immune responses are overrepre-
sented in the set of Cyclin T1-dependent mRNAs in macrophages
[13], suggesting that proper macrophage function may require the
down-regulation of miR-198. A topic for future research will be
the study of signals and mechanisms that lead to the down-
regulation of miR-198 in macrophages.
It is notable that Cyclin T1 mRNA levels are reduced ,30–
60% when Cyclin T1 protein levels are up-regulated following
monocyte differentiation (Figure 5) [10,14]. The explanation for
this phenomenon is not clear, but it is possible that transcription of
the Cyclin T1 gene is not increased during differentiation, as the
promoter for Cyclin T1 appears to be constitutively active [22].
The active translation of Cyclin T1 mRNA following the relief of
repression by miR-198 may reduce the mRNA half-life, and if a
transcriptional induction of the Cyclin T1 gene does not occur, a
decrease in the amount of Cyclin T1 mRNA will result.
Expression pattern of miR-198 and other potential mRNA
targets
miR-198 is in the 39UTR (exon 11) of FSTL1, a gene that has
recently been shown to enhance inflammatory cytokine produc-
tion in a monocytic cell line after mitogen stimulation [35]. The
correlation between the FSTL1 transcript and miR-198 levels has
not yet been established, but FSTL1 transcripts are not detectable
in peripheral blood leukocytes [36], suggesting that the processing
of the FSTL1 primary transcript for protein production or miR-
198 might be mutually exclusive.
Little information is available concerning potential functions
and mRNA targets for miR-198. Although expression in
monocytes was not examined in a previous study in 40 normal
human tissues, miR-198 expression was found to be generally low
and restricted to only a few tissues [37]. In hepatic tumors,
expression of miR-198 was found to be down-regulated relative to
normal liver parenchyma [38]. A genetic analysis identified a SNP
in the miR-198 gene that has a nominally significant allelic
association with schizophrenia [39]. We used both PicTar [40]
and TargetScan [41,42] to identity mRNAs that are predicted to
be targets of miR-198. This analysis identified 41 mRNAs in
common between the two programs that are potential targets for
miR-198. However, no common features from the proteins
encoded by these mRNAs were apparent. An intriguing predicted
target for miR-198 is in the 39UTR of PTEN, a negative regulator
of the PI3-kinase pathway, and PTEN is involved in LPS signaling
in monocytes/macrophages [43]. Interestingly, the HIV-1 Tat
protein has been shown to decrease expression of PTEN in
primary human macrophages [44], which is consistent with our
Figure 7. Down-regulation of Cyclin T1 by miR-198 inhibits
HIV-1 proviral gene expression and HIV-1 replication. (A) Left
panel: Immunoblot analysis of Cyclin T1 levels in MM6 cells treated with
or without PMA for 48 hours. Right panel: MM6 cells were mock-
transfected or transfected with shGFP- or shmiR-198-expressing
plasmids and then treated with PMA. Cells were harvested 48 hours
after PMA treatment and examined for Cyclin T1 expression. b-actin
expression was analyzed as a loading control. (B) A HIV-1 NL4-3 firefly
luciferase proviral reporter plasmid was co-transfected with shGFP- or
shmiR-198-expression plasmids and a renilla luciferase reporter internal
control plasmid into MM6 cells. Cells were treated with PMA
immediately after transfection, and cell extracts were prepared
48 hours later and divided into two equal portions for dual-luciferase
assays and immunoblot analyses. Relative luciferase activity was
determined by normalizing firefly luciferase activity to renilla luciferase
activity. Two independent transfection experiments were performed; in
one experiment transfections were performed in duplicate. For
immunoblots to examine Cyclin T1 expression, panel on left represents
the single transfection experiment, while panel on right represents the
duplicate transfection experiment. Luciferase assays shown are the
average of the three transfections with bars representing the range in
the three measurements. C. MM6 cells were transfected with shGFP- or
shmiR-198-expression plasmids in two independent experiments.
Cultures were treated with PMA immediately after transfection and
one day later were infected with HIV-1 strain SF162. Expression of p24 in
culture supernatants was measured at three days post-infection in
experiment 1 and at four days post-infection in experiment 2. The data
in experiment 2 show the means6SD of infections carried out in
triplicate in the control (shGFP) or shmiR-198 plasmid.
doi:10.1371/journal.ppat.1000263.g007
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macrophages (Figure 8). Because overexpression of PTEN
enhances HIV-1 expression [45], it is possible that the anti-
HIV-1 function of miR-198 involves targeting cellular cofactors in
addition to Cyclin T1.
We note that miR-223,which has been shown to target HIV-1
in the 39 end of the viral genome and repress its expression [46],
was identified in our miRNA profiling as a miRNA that is down-
regulated during macrophage differentiation (Figure 1). This
further emphasizes the power of miRNA profiling in identifying
miRNAs associated with specific processes. Finally, given the ,5
kb of 39UTR sequence in Cyclin T1 mRNA, it is possible if not
likely that miRNAs in addition to miR-198 are involved in
repression of Cyclin T1 expression in monocytes and other cell
types. Our miRNA profiling only assayed 321 miRNAs and given
that it is estimated that there are .800 human miRNAs, it is
possible that additional miRNAs that regulate Cyclin T1 in
monocytes and other cell types await discovery.
Materials and Methods
Primary cell preparations
Peripheral blood mononuclear cells (PBMCs) were isolated from
healthy blood donors (Gulf Coast Regional Blood Center,
Houston, TX) by Isolymph density gradient centrifugation
(Gallard-Schlesinger). Primary monocytes were isolated from
PBMCs by negative selection using monocyte Isolation Kit II
(Miltenyi Biotec). Macrophages from the same donors used for
monocyte preparations were obtained by adherence of PBMCs to
dishes in RPMI medium supplemented with 1% human serum for
one hour as described previously [10]. Adhered cells were washed
three times with phosphate buffered saline (PBS), incubated with
complete RPMI medium (10% fetal bovine serum and 1%
Penicillin-Streptomycin liquid, GIBCO) for two hours, washed
three times with PBS, and cultured with complete RPMI medium
containing GM-CSF (10 units/ml) for four to five days before
RNA isolation. Purities of monocyte and macrophage prepara-
tions were evaluated by flow cytometry using CD14 as a monocyte
marker and CD71 as a macrophage marker. The purity of
monocyte and macrophage preparations was determined to be $
92% (data not shown). Resting CD4
+ T cells were isolated and
activated as previous described [9].
MiRNA microarray analysis, quantification, and target
prediction
To prepare RNA samples for miRNA microarray or miRNA
quantification, total RNA enriched with small RNAs was isolated
using mirVana miRNA isolation kit (Ambion) according to the
manufacturer’s protocol. RNA preparations from Donor1 and
Donor2 were sent to LC Sciences (Houston, TX) for miRNA
microarray analysis using the mParaflo microfluidic chips and
detailed process can be found at http://www.lcsciences.com.
Briefly, probes for miRNAs were in situ synthesized on chips using
photogenerated reagent chemistry with repeats for each probe to
allow statistical analysis. Version 7.1 arrays were used to detect
321 unique mature miRNAs. RNA samples from the same donor
for comparison were labeled with Cy3 or Cy5 for hybridization,
and the labeling was reversed between the same cell populations
from the two donors. Quality control was done by hybridizing a
group of control oligos to evaluate array quality as well as by
mixing a fixed amount of 20-mer RNA oligos to samples as
external controls. Data were processed by subtracting background
and normalized the signals using a LOWESS filter [47]. A
detectable transcript was defined by fulfilling the following criteria:
(1) signal intensity .36background standard deviation; (2) spot
CV (standard deviation/signal intensity) ,0.5; (3) signals from at
least 50% of the repeating probes are above detection level. The
ratio of the two colors of detected signals and p-values of the t-test
were calculated. A cut-off at p-value , 0.01 was used to define a
differentially expressed miRNA. A heat maps for all differentially
expressed miRNAs was generated by Cluster [48]. The primary
data can be accessed at http://www.bcm.edu/molvir/labs/
herrmann-rice-lab/Rice-Herrmann_Pages-Data.htm.
Figure 8. HIV-1 infection of primary macrophages affects miR-198 as well as Cyclin T1 mRNA levels. Macrophages were infected with
HIV-1 SF162 strain for seven days and total RNA was isolated and assayed for: (A) expression levels of miR-198; (B) Cyclin T1 and a-tubulin mRNAs.
U6B snRNA was used for normalization of miR-198 and b-actin mRNA was used for normalization of mRNAs. Bars represent the range in the three
measurements.
doi:10.1371/journal.ppat.1000263.g008
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miR-24 were used to verify microarray results of Donor1 and
Donor2 by mirVana qRT-PCR detection kit and primer sets
(Ambion). A 25-cycle of PCR was preformed and the PCR
products were resolved by gel electrophoresis using a 3.5% agarose
gel to examine the ,90 bp products. Quantification of band
intensity was done by analysis of the gel pictures with ImageQuant
(Molecular Dynamics). TaqMan MicroRNA assays (Applied
Biosystems) were use to quantify mature miR-198, U6B snRNA,
and U3B snRNA. Target prediction was done using primarily
RNAhybrid [49] and also microInspector [50].
Poly(A) signal usage of Cyclin T1 mRNA
Total RNA was isolated from cells using RNeasy mini kit
(Qiagen) and treated with DNase I (Invitrogen) for reverse
transcription using ThermoScript RT-PCR system (Invitrogen)
and primer T7-(TTT)6-V (59-TTGTAATACGACTCACTA-
TAGGGC-TTTTTTTTTTTTTTTTTT-A/G/C-39). PCR was
performed using reverse primer for T7 and forward primers specific
for each poly(A) signal (P1: 59-gggccaatggtcacaacacg-39,P 2 :5 9-
TGTATATCCGAAGGGAAACAGC-39,P 3 :5 9-GCTGAACTG-
TAGTGAAGCATCG-39,P 4 :5 9-CAGCATATTATTCTGC-
CATTGC-39, and P5: 59-ATTGTTACATGAATACCTGG-39).
PCR products were resolved on a 2% agarose gel and bands of
,400bp were extracted from the gel, purified with QIAquick gel
extraction kit (Qiagen) for TOPO TA cloning (Invitrogen) for DNA
sequencing.
Ectopic expression of miR-198 and reporter assay
An shRNA strategy was utilized to express miR-198 (shmiR-
198) or a control shRNA designed to target GFP (shGFP) from a
pCL-based retroviral vector [51]. BOSC cells were used to
generate viruses by co-transfecting shGFP or shmiR-198 plasmid
and an amphotropic packaging vector using lipofectamine 2000
(Invitrogen). Viruses were harvested 24 hours after transfection for
infection of HeLa cells for another 24 hours. Infected HeLa cells
were then selected by puromyocin treatment (1 mg/ml) for two
days to obtain cell pools expressing shGFP or shmiR-198. As
quantified by TaqMan MicroRNA assays (Applied Biosystems),
miR-198 was expressed .400-fold in cell pools expressing shmiR-
198 relative to pools expressing shGFP.
Full-length or fragments of Cyclin T1 39UTR, or copies of three
predicted target sequences were inserted between the luciferase
gene and the poly(A) signal of a pGL3-based firefly luciferase
reporter driven by CMV immediate early promoter (Promega).
The full-length Cyclin T1 39UTR was cloned by PCR reactions
using BAC clones as templates and extra ,500bp genomic
sequence downstream of the poly(A) signal was included for
cloning into the luciferase reporter (pU3-full). Fragments of Cyclin
T1 39UTR were cloned by PCR reactions using pU3-full as
template and primers containing XbaI site at the 39 ends for
subsequent cloning. Individual predicted target sequence was
obtained by annealing complementary oligos containing copies of
the predicted sequence and 39 overhang for XbaI site ligation.
Mutagenesis was done using QuikChange Site-Directed Muta-
genesis Kit (Stratagene) according to manufacturer’s instructions.
For reporter plasmid experiments, 25 ng of each firefly
luciferase reporter plasmid was co-transfected into shGFP- or
shmiR-198-expressing HeLa cell pools along with 10 ng of
thymidine kinase promoter-driven renilla reporter plasmid
(pTK-RL, control for transfection efficiency) using Lipofectamine
2000 (Invitrogen). To further boost miRNA expression, 1ug of
shGFP- or shmiR-198 plasmids were also co-transfected. Cells
were harvested 24 hours after co-transfection and luciferase
activities were measured using Dual-Luciferase Reporter Assay
System (Promega). Relative luciferase activity was calculated by
dividing firefly luciferase activity by renilla luciferase activity (FL/
RL). Relative expression was obtained by normalization to FL/RL
in shGFP-expressing cells transfected with the same firefly reporter
plasmid.
For the transfection experiment to examine the requirement of
the Cyclin T1 39UTR for repression by miR-198, pHA-Cyclin T1
[4] (50 ng), p198T (50 ng) and pTK-renilla luciferase (10 ng) were
co-transfected into HeLa cells with pre-miR-Control (50 nmol),
pre-miR-198 (50 nmol) or siCyclin T1 (50 nmol) in a 24-well
culture dish using Lipofectamine (Invitrogen). Cells were harvested
at 24 hours post-transfection and split into two portions for
immunoblot analysis and dual-luciferase assays.
MiRNA precursor/inhibitor transfections, Cyclin T1
immunoblots, and RT-real-time-PCR for cellular mRNAs
miRNA precursors (6.25 pmole to 100 pmole, Applied
Biosystems) or an siRNA targeting Cyclin T1 coding region
(Dharmacon) were transfected into HeLa or 293T cells (,30%
confluent at times of transfection) using oligofectamine (Invitro-
gen). Cells were harvested by direct lysis with 16loading buffer for
immunoblot analysis at 72 hours post-transfection. Independent
transfections were performed in HeLa cells for total RNA isolation
using RNeasy mini kit (Qiagen) and RNA were subjected to RT-
real-time-PCR assays for quantification of Cyclin T1, b-actin,
GAPDH, and a-tubulin mRNA levels using the Bio-Rad MyIQ
single color detection system as previously described (Sung and
Rice, 2006). Primer sequences designed by the Beacon Designer




miR-198 inhibitor (anti-miR-198) or control miRNA inhibitor
(anti-miR-Control) was transfected into primary monocytes (250
pmole inhibitors/3610
6 cells) obtained from healthy donors using
the Amaxa Nucleofector system. Cells were harvested by direct
lysis at 18 or 24 hours after transfection for immunoblot analysis to
detect Cyclin T1 and b-actin protein expression. Pre-miR-198 or
pre-miR-Control was also transfected with the Amaxa system into
primary monocytes (250 pmole inhibitors/3610
6 cells) and cells
were treated with GM-CSF to induce differentiation for 48 hours.
Cyclin T1 protein levels were quantified by scanning X-ray films
with Personal Densitometer SI and analyzed with ImageQuant
(Molecular Dynamics), followed by normalization to b-actin
protein levels. Antibodies for immunoblot were purchased from
Santa Cruz Biotechnology.
Transfections and HIV-1 infection in MM6 cells
The promonocytic cell line MM6 was cultured and transfected
according to the protocols described at http://www.monocytes.de.
Briefly, MM6 cells were propagated in RPMI 1640 (Invitrogen)
supplemented with L-glutamine (2 mM, Invitrogen), penicillin-
streptomycin (400 U/ml and 400 mg/ml, Invitrogen), 16non-
essential amino acids (Invitrogen), OPI media supplement (Sigma),
and 10% certified fetal bovine serum tested for endotoxin
(Invitrogen). Low passage MM6 cells were used and cells were
kept at a concentration of no more than 5610
6/ml to maintain a
low endogenous Cyclin T1 protein expression level. For HIV-1
wild type LTR-luciferase reporter assays, 5610
6 MM6 were
washed with RPMI 1640 and incubated with 3 mg shGFP- or
shmiR-198-expressing plasmids, 1 mg HIV-1 luciferase reporter
plasmid, 1 mg pTK-RL, and 250 mg/ml DEAE dextran (Sigma)
for 90 minutes. The HIV-1 luciferase reporter plasmid contains a
miR-198 Represses Cyclin T1
PLoS Pathogens | www.plospathogens.org 11 January 2009 | Volume 5 | Issue 1 | e1000263deletion in the env gene, a replacement of the nef gene with firefly
luciferase gene, and a deletion in the vpr gene. Cells and plasmids
were mixed every 30 minutes by gently rocking the tube during
incubation and then treated with 10% DMSO for 3 minutes. After
washing out DMSO, cells were treated with PMA (10 mg/ml final
concentration), harvested 48 hours later, and divided into two
equal portions for dual-luciferase assays and immunoblot analyses
as described above. HIV-1 infections with strain SF162 (100
TCID50 units per culture in 6 well dishes) were performed one day
after PMA treatment. Measurements of p24 expression (RETRO-
tek, ZeptoMetrix Corporation) in culture supernatants were
performed at day three or four post-infection as indicated.
HIV-1 infection of primary macrophages
Macrophages were allowed to differentiate for five days from
monocytes and incubated with HIV-1 SF162 strain at 6000
TCID50 per 10 cm
2 dish for two hours (37uC, 5% CO2) with
intermittent shaking. Following virus adsorption, cells were
washed three times with PBS. Cells were then supplied with
complete RPMI medium and incubated for seven days to allow at
least two rounds of infection. Measurements of p24 expression
(RETROtek, ZeptoMetrix Corporation) at day four and day seven
of infection were performed to verify productive infections. At day
seven post-infection, cells were washed with PBS three times for
total RNA isolation for miR-198 quantification and mRNA
quantification as described above.
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